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We tested eﬀects of auricular acupressure on peri- and early postmenopausal women with anxiety (PPWA). Fifty PPWA were
randomly assigned to the auricular acupressure group (AG) or the sham group (SG). After 3 meals and before sleep every day for 4
weeks, the AG received auricular acupressure on the bilateral ear shenmen and subcortex points for 3min per point on alternating
ears. The SG received sham auricular acupressure. The Alprazolam was reduced from 0.5mg/day at baseline to 0.3mg/day 4 weeks
after auricular acupressure (4W) in the AG (P<. 05) whereas maintained at 0.5mg/day in the SG (P>. 05). The Zolpidem was
reduced from 3.0mg/day at baseline to 1.5mg/day at 4W (P<. 05) whereas was reduced from 2.4mg/day to 1.9mg/day at 4W in
the SG (P>. 05), thus, signiﬁcant tapering medication, suggesting auricular acupressure is helpful to PPWA.
1.Introduction
In menopausal women, anxiety and accompanying insomnia
generate a domino eﬀect that can multiply symptoms associ-
ated with menopause and depression [1]. These burdens last
for more than a few months or even several years, and such
conditions often aﬀect quality of life [2]. According to the
American Psychiatric Association Diagnostic and Statistical
Manual Fourth Edition (DSM-IV, TR) [3], anxiety is clas-
siﬁed as an ongoing concern, worry, or sense of impending
disaster, a feeling of tension, and an inability to relax. The
epidemiology of natural menopause is deﬁned as a lack of
menstruation for 12 months in the absence of other causes
such as pregnancy or breastfeeding [4]; however, no such
standardexistsforperimenopause.Perimenopauseischarac-
terized by irregular menstrual cycles or less than 12 months
without menstruation, but the only index in the ﬁrst 2 or
3 days of the menstrual cycle is an elevation in the follicle-
stimulatinghormone(FSH)[5].AcohortstudybyaHarvard
research team found that signiﬁcant new depressive symp-
tomsinmenopausalwomenhaveatleasttwicethepossibility
of leading to depression than in the pre-menopausal stage
[6].Anxietyandinsomniacanbepredictorsofdepressionfor
womeninthisperiod[7].Anxietycanalsopredictvasomotor
symptoms [8]. An increasing trend of hot ﬂashes, sleep dis-
turbance, physical and mental symptoms, muscle and joint
pain, and other symptoms at diﬀerent stages of menopause
may aﬀect women’s quality of life [9]. Although estrogen2 Evidence-Based Complementary and Alternative Medicine
therapy has an eﬀect on vasomotor symptoms, depression,
anxiety, and insomnia in menopausal and postmenopausal
women [10], the Women’s Health Initiative (WHI) reported
an increase in cases of coronary heart disease, stroke, venous
thrombosis, and dementia cases after hormone therapy [11].
Some studies show that the drugs of choice for insomnia in
menopausal and postmenopausal women, such as the non-
benzodiazepines Zolpidem and Eszopiclone, are eﬀective for
the short term, and improve sleep, mood, quality of life, and
menopause-related symptoms within 4 weeks [12, 13]; how-
ever, long-term use of these drugs may still cause psycholog-
ical or physical dependence.
Acupuncture reduces anxiety through the regulation of
neurotransmitters by reducing the platelet 5-hydroxytrypt-
amine (5-HT) concentration and plasma adrenocorticotro-
phic hormone (ACTH) [14]. Some randomized controlled
studies showed that ear acupuncture before surgery can re-
duce anxiety related to surgery [15] and can improve anxiety
in everyday life for healthy participants [16].
We used evidence-based methods to review the history
andresearchoftheeﬀectsofearacupunctureonanxiety[17–
19]. No previous study has explored the therapeutic eﬀect of
a combination of auricular acupressure and drug treatment
for women suﬀering from anxiety and insomnia during the
menopausal stage; therefore, we designed this protocol in an
attempt to provide convenient and eﬀective treatment and to
reduce dependence on sedatives, thereby improving quality
of life for participants.
2.MaterialsandMethods
2.1. Participants. Ninety-one peri- and early postmeno-
pausal women with anxiety (PPWA) were recruited at the
Department of Psychiatry, Chang-Hua Hospital, Depart-
ment of Health, from January 1, 2010 to December 31, 2010.
Forty-one patients were excluded from the study prior to
signing informed consent: 17 patients were aged more than
65 years old, 12 patients had experienced menopause for
more than 10 years, 1 had a serious medical disease, 3 had
major psychiatric illnesses, 2 had recently used hormones,
1 regularly used Chinese herbs, and 3 refused the trial. The
inclusion criteria were (1) between 40 and 60 years of age;
(2) irregular menstruation for less than 12 months or meno-
pause for less than 10 years; (3) FSH plasma concentrations
of 14IU/L; (4) anxiety secondary to perimenopause or
early post-menopause. Participants provided written in-
formed consent after a full explanation of the purpose and
process of the study. Exclusion criteria were (1) serious
medical disorders (e.g., asthma, epilepsy, or heart, liver, or
renal failure); (2) substance dependence or abuse (e.g., alco-
hol, drugs, hypnotics, and analgesics); (3) contraindications
to sedatives and hypnotic drugs; (4) contraindications to
acupuncture treatment; (5) suicidal and violent tendencies;
(6) existence of primary anxiety disorders and other major
axis I psychiatric diagnoses (e.g., schizophrenia, major de-
pression, and bipolar disorders); (7) lack of fulﬁllment of
the standard type and dosage of the drugs set in this study;
(8) use of hormone therapy for menopausal symptoms;
(9) use of traditional Chinese medicine for mental condi-
tions; (10) refusal to sign the informed consent form. The
plan wasreviewedand approved beforethe trial by the China
Medical University Hospital Institutional Review Board
(CMUH IRB no. DMR98-IRB-291-1).
2.2. Design and Sample Size. The present study is a random-
ized double-blind control pilot study of a combination of
modern medicine and complementary therapy of auricular
acupressure to research the change in anxiety symptoms in
peri- and early postmenopausal women. Remission of anxi-
ety is deﬁned as a reduction in score on the Hamilton Anxi-
ety Rating Scale (HAMA) [20] 50% and Clinical Glob-
al Impression-severity/Clinical Global Impression-Improve-
ment/(CGI-S/CGI-I) [21] 2, and improvement of meno-
pausal symptoms is deﬁned as a reduction in score on the
Menopause Rating Scale (MRS) [22] 50%.
Because the present study was a pilot study, no basis ex-
isted on which to calculate power or sample size.
2.3. Randomized and Grouping. Fifty peri- and early post-
menopausal women with anxiety were assigned to 1 of 2
groups by a computerized random numbers table, as follows:
(1) in the auricular acupressure group (AG), participants
received ear adhesive tape with magnetic beads (200 Gauss,
Xiang Yu International Co., Ltd., Taiwan) on the ear shen-
men (MA-TF1) and subcortex (MA-AT1) points for both
ears from a Chinese medicine physician with more than 8
yearsofexperienceinauricularacupressure.Acupressurewas
applied toeachacupoint onalternating earsfor3min ateach
point after 3 meals and before bedtime every day for 4 weeks.
Theearadhesivetapewithmagneticbeadswaschangedtwice
a week, and the location of magnetic beads was reconﬁrmed
again prior to the changes; thus, they were changed 8 times
in the 4 weeks; (2) in the sham acupressure group (SA), the
methods were identical to AG, but the ear adhesive tape had
no magnetic beads. The checklist of consolidated standards
ofreportingtrials(CONSORT)wascomplete[23].Thecom-
plete details of the intervention are presented in Table 1
in conformance to standards for reporting intervention in
controlledofacupuncture[24].Allparticipantswereallowed
to receive doses of Alprazolam 0 to 2mg/day and Zolpidem
0 to 10mg/day, gradually tapering the dosage of each drug
during the period of treatment.
2.4. Assessment and Outcome Measure. The assessment was
performed by a psychiatric specialist who was blind to
the group. The participants were evaluated at baseline
(before auricular acupressure) and 4 weeks after auricular
acupressure (4W). The type and dosage of medication were
also recorded at each visit.
Primary outcome measures focused on the diﬀerence in
dosage of Alprazolam or Zolpidem between the baseline and
at 4W and the diﬀerence in HAMA, MRS, CGI-S, and CGI-I
scores between baseline and at 4W. The secondary outcome
measure was the diﬀerence in quality of life according to
Short Form Health Survey (SF-36) scores and its subscores
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Table 1: Standards for reporting interventions in clinical trials of
acupuncture (STRICTA 2010).
Acupoint
rationale
(1) According to meridian theory of traditional
Chinese medicine.
(2) MA-TF1 (ear shenmen), MA-AT1 (ear
subcortex).
Acupressure
detail
(1) Bilateral ear acupoints.
(2) Four magnetic beads.
(3) Magnetic beads on the skin surface in
acupressure group (AG), and without magnetic
beads in sham group.
(4) Pressure feeling.
(5) Alternating ears for 3min at each point.
(6) Magnet bead, 200 Gauss, Xiang Yu
international Co., Ltd., Taiwan.
Treatment
regimen
(1) Four times (after 3 meals and before
bedtime) every day for 4 weeks.
Cointerventions
(1) None of herbs, moxibustion, cupping,
massage, exercise, advice dietary or lifestyle
modiﬁcation.
Practitioner
background
(1) License-certiﬁcated Chinese medical doctor
with more than eight years of acupuncture
experience.
Control
intervention (1) Nil.
The HAMA contains 14 items measured with a 5-point
L i k e r ts c a l e .T h es c o r ei sf r o m0( n os y m p t o m s )t o4( e x -
tremely severe). The present study calculated only the total
scores. The higher the total score was, the more serious were
the symptoms of anxiety. The MRS includes 11 items that
can be divided into 3 subscales: the urogenital, somatic and
psychological domains. It uses a 5-point Likert scale from 0
(no symptoms) to 4 (extremely severe). The study calculated
only the total scores. The higher the total score, the more
serious the symptoms of menopause. The SF-36 contains 36
itemstoassessphysicalandmentalhealth,dividedinto8sub-
scales: physical function (PF), social function (SF), role lim-
itations caused by physical problems (RP), role limitations
caused by emotional problems (RE), mental health (MH),
energy/vitality (VT), body pain (BP), and general perception
of health (GH). This study assessed each subscale; higher
scores presented a better health status. The CGI-S contains
7 items from 1 to 7 points. A higher score indicates greater
severity. The CGI-I contains 7 items from 1 to 7 points. A
lower score represents a higher degree of improvement.
2.5. Statistical Analysis. The data were analyzed using statis-
tical software SPSS 18.0 version. The categorical data was
analyzed using Pearson x2 tests or Fisher’s exact tests. In-
dependent t-tests (two-tailed) were used to analyze the va-
riables between the AG and SG groups, and paired t-tests
(two-tailed) were used to analyze the intragroup variables.
Signiﬁcance of statistical diﬀerence was set to P<. 05.
3. Results
3.1. Baseline Characteristics of Demographic Data. Of the
50PPWA enrolled in the present study, 27 participants were
Table 2: Demographic characteristics at baseline.
AG (n = 25) SG (n = 19) P value
Age (years) 53.56 ±4.63 54.42 ±6.42 .607t
Education (years) 8.92 ±3.71 9.47 ±4.58 .660t
Parity 2.71 ±1.31 3.12 ±1.36 .360t
Menarche (years) 14.25 ±1.77 13.67 ±1.24 .267t
Marital status .179c
Married 24 (96%) 17 (89.5%)
Single 1 (4%) 0 (0.0%)
Divorced 0 (0.0%) 2 (10.5%)
Menopausal status .986c
Perimenopause 5 (20.9%) 4 (21.1%)
Post-menopause 19 (79.1%) 15 (78.9%)
FSH 58.7 ±28.26 6 .2 ±35.6. 4 5 t
Data are expressed as mean ± standard deviation (SD). AG: auricular
acupressure group; SG: sham group; FSH: follicle stimulating hormone;
t:S t u d e n t ’ st-test; c: Pearson chi-square or Fisher’s exact test.
Table 3: Inﬂuencing factors at baseline.
AG (n = 25) SG (n = 19) P value
Prior use of hormone 9 (36%) 13 (68.4%) .03
Herbal medicine 11 (44%) 4 (21%) .11
Smoking habit 1 (4%) 0 (0%) .38
Alcohol habit 1 (4%) 0 (0%) .38
Caﬀeine habit 6 (24%) 2 (11%) .23
BSRS 7.6 ±4.18 .0 ±3.2. 7 6 t
AG: auricular acupressure group; SG: sham group; BSRS: Brief Symptom
Rating Scale. t:S t u d e n t ’ st-test.
assigned to the AG and 23 to the SG. Only 25 participants in
theAGcompletedthetrial.Onestoppedbecauseofdizziness,
and 1 stopped because of other reasons. Nineteen partici-
pants completed the trial in the SG; 2 stopped because they
feltnoeﬀect,and2couldnotadheretothetimesinthestudy.
Therefore, 44 participants completed the trial (Figure 1).
The baseline characteristics of the AG and SG participants,
which comprised age, education, parity, age at menarche,
marital status, menopausal status (perimenopause and post-
menopause), and levels of FSH, were similar between the 2
groups (all P>. 05; Table 2). In addition, factors inﬂuencing
anxiety investigated prior to the trial, namely, use of herbal
medicine,smokinghabits,alcoholhabits,caﬀeinehabits,and
Brief Symptom Rating Scale (BSRS), were similar between
the AG and the SG (all P>. 05; Table 3). The exception was
that prior use of FSH was greater in the SG than in the AG
(P = .03; Table 3).
3.2. Eﬀect of Auricular Acupressure on PPWA. The HAMA
scores at baseline and at 4W were similar between the AG
and the SG (both P>. 05; Table 4). The HAMA scores were
higher at baseline than at 4W in the AG and in the SG (both
P<. 05; Table 4), and the diﬀerence in HAMA score between
baseline and 4W was similar between the 2 groups (P>. 05;
Table 4).4 Evidence-Based Complementary and Alternative Medicine
Perimenopausal and early postmenopausal women
with anxiety were enrolled (n = 91)
Forty-one patients were excluded
More than 65 years of age (n = 17)
Menopause for more than 10 years (n = 12)
Serious medical disease (n = 1)
Major psychiatric disorders (n = 3)
Current use of hormone (n = 2)
Current use of Chinese herbs (n = 3)
Randomized (n = 50)
Auricular acupressure group (n = 27)
(1) Ear adhesive tape with magnetic beads on ear
shenmen and subcortex points of both ears for
3 min on each point on alternating ears after 3
meals and before sleep.
(2) Ear adhesive tape changed twice a
week for 4 weeks
Sham group (n = 23)
(1) Ear adhesive tape without magnetic beads on
ear shenmen and subcortex points of both ears
for 3 minutes on each point on alternating ears
after 3 meals and before sleep.
(2) Ear adhesive tape changed twice a
week for 4 weeks
Complete trial (n = 25)
n = 1)
Complete trial (n = 19)
Dropout (n = 4): feeling no eﬀect
(n = 2), time reasons (n = 2)
Statistical analysis
Refusal of trial (n = 3)
Dropout (n = 2): dizziness (n = 1)
Work reason (
Figure 1: Flowchart.
The MRS scores at baseline and at 4W were similar for
the AG and the SG (both P>. 05; Table 4). The MRS scores
were higher at baseline than at 4W in the AG and in the SG
(both P<. 05; Table 4), and the diﬀerence in MRS score be-
tween baseline and 4W was similar for the 2 groups (P>. 05;
Table 4).
The CGI-S scores at baseline and at 4W were similar for
the AG and the SG (both P>. 05; Table 4). The CGI-S scores
were higher at baseline than at 4W in the AG and in the SG
(both P<. 05; Table 4), and the diﬀerence between CGI-S
score at baseline and at 4W was similar for the 2 groups
(P>. 05; Table 4).
The CGI-I scores at baseline and at 4W were similar for
the AG and the SG (both P>. 05; Table 4). The CGI-I scores
were higher at baseline than at 4W in the AG and in the SG
(both P<. 05; Table 4), and the diﬀerence between CGI-I
score at baseline and at 4W was similar for the 2 groups (P>
.05; Table 4).
TheAlprazolamdosesatbaselineandat4Wweresimilar
for the AG and the SG (both P>. 05; Table 4). The Alpra-
zolam doses were greater at baseline than at 4W in the AG
(both P<. 05; Table 4), but not in the SG (P>. 05; Table 4).
The diﬀerence in Alprazolam doses between baseline and
4W was similar for the 2 groups (P>. 05; Table 4).
The Zolpidem doses at baseline and at 4W were similar
for the AG and the SG (both P>. 05; Table 4). The Zolpidem
doseswerehigheratbaselinethanat4WintheAG(bothP<
.05; Table 4), but not in the SG (P>. 05; Table 4). The dif-
ference between Zolpidem doses at baseline and at 4W was
similar for the 2 groups (P>. 05; Table 4).
3.3. Eﬀect of Auricular Acupressure on Subscores of SF-36 in
PPWA. The PF sub-score of SF-36 at baseline and at 4W
were similar for the AG and the SG (both P>. 05; Table 5).
The PF subscores of SF-36 were higher at 4W than at
baseline in the AG (both P<. 05; Table 5), but not inEvidence-Based Complementary and Alternative Medicine 5
Table 4: Eﬀect of auricular acupressure on peri-menopausal and
early postmenopausal women with anxiety.
AG (n = 25) SG (n = 19)
Baseline 4W Baseline 4W
HAMA 17.8 (6.2)a 8.0 (5.5)a,b 19.6 (5.5) 11.0 (6.3)b
MRS 11.8 (5.9)a 6.4 (5.8)a,b 14.5 (6.1) 8.2 (4.9)b
CGI-S 3.8 (0.7)a 2.3 (0.9)a,b 4.1 (0.7) 2.7 (1.0)b
CGI-I 4.4 (0.5)a 2.0 (0.9)a,b 4.5 (0.5) 2.6 (1.1)b
Alprazolam
(mg/day) 0.5 (0.4)a 0.3 (0.3)a,b 0.5 (0.6) 0.5 (0.6)c
Zolpidem
(mg/day) 3.0 (4.0)a 1.5 (3.1)a,b 2.4 (2.6) 1.9 (3.4)c
AG: auricular acupressure group; SG: sham group; Baseline: prior to
auricular acupressure; 4W: at 4 week after auricular acupressure; HAMA:
Hamilton Anxiety Rating Scale; MRS: Menopause Rating Scale; CGI-S:
Clinical Global Impression-Severity; CGI-I: Clinical Global Impression-
Improvement; aNo signiﬁcant diﬀerence between AG and SG groups (P>
.05). bSigniﬁcant diﬀerence between baseline and 4W (P ≤ .05). cNo
signiﬁcant diﬀerence between baseline and 4W (P>. 05).
the SG (P>. 05; Table 5). The diﬀerence between PF sub-
scores of SF-36 at baseline and at 4W was similar for the 2
groups (P>. 05; Table 5).
The RP and RE subscores of SF-36 at baseline and at 4W
were similar for the AG and the SG (both P>. 05; Table 5).
TheRPandREsubscoresofSF-36weregreaterat4Wthanat
baseline in the SG (both P<. 05; Table 5), but not in the AG
(both P>. 05; Table 5). The diﬀerence between the RP and
RE subscores of SF-36 at baseline and at 4W was similar for
the 2 groups (both P>. 05; Table 5).
The VT, MH, BP, and GH subscores of SF-36 at baseline
and at 4W were similar for the AG and the SG (all P>. 05;
Table 5). The VT, MH, BP, and GH subscores of SF-36 were
greater at 4W than at baseline in the AG and in the SG (all
P<. 05; Table 5), whereas the diﬀerence between VT, MH,
BP, and GH subscores of SF-36 at baseline and at 4W were
similar for the 2 groups (all P>. 05; Table 5).
The SF sub-score of SF-36 at baseline and at 4W were
similar for the AG and the SG (both P>. 05; Table 5). The SF
sub-score of SF-36 was similar at baseline and at 4W in the
AGandintheSG(bothP<. 05;Table 5).ThediﬀerenceinSF
sub-score of SF-36 between baseline and 4W was similar for
the 2 groups (P>. 05; Table 5).
4. Discussion
The results of the present study indicate that the diﬀerence
between HAMA, MRS, CGI-S, and CGI-I scores at baseline
and at 4W was similar for the AG and the SG. The doses
of Alprazolam and Zolpidem were reduced from baseline to
4W in the AG, but not in the SG. Therefore, we suggest
that auricular acupressure improved PPWA, although the
participantsofprioruseofhormonetherapywasmoreinthe
SG than AG with signiﬁcant diﬀerence, because the severity
of anxiety was not statistically diﬀerent at baseline, the eﬀect
of hormone on outcome may be minimal. Both Alprazolam
and Zolpidem are sedative drugs widely used to treat PPWA
or insomnia [12, 13], and HAMA, MRS, CGI-S, and CGI-I
scores can be used to evaluate menopausal anxiety [22]. This
Table 5: Eﬀect of auricular acupressure on subscores of SF-36 in
peri-menopausal and early postmenopausal women with anxiety.
AG (n = 25) SG (n = 19)
Baseline 4Ws Baseline 4W
PF 80.2 (15.0)a 87.8 (14.9)a,b 73.4 (21.9) 79.7 (20.8)c
RP 59.0 (42.6)a 75.0 (36.1)a,c 46.1 (47.3) 75.0 (37.3)b
RE 52.0 (44.2)a 68.0 (41.4)a,c 49.1 (43.6) 82.5 (32.1)b
VT 54.6 (22.4)a 65.2 (19.6)a,b 49.2 (20.6) 61.3 (20.7)b
MH 54.4 (18.4)a 65.3 (19.4)a,b 50.7 (15.5) 64.4 (16.6)b
SF 73.0 (19.3)a 79.0 (17.2)a,c 68.4 (19.7) 76.3 (16.6)c
BP 69.1 (15.7)a 76.7 (13.5)a,b 60.7 (14.2) 73.8 (19.7)b
GH 45.8 (16.8)a 62.2 (22.1)a,b 36.6 (19.6) 55.8 (23.2)b
AG: auricular acupressure group; SG: sham group; Baseline: prior to
auricular acupressure; 4W: at 4 week after auricular acupressure; SF-36:
Short Form Health Survey; PF: physical function; SF: social function; RP:
role limitations due to physical problems; RE: role limitations due to
emotionalproblems;MH:mentalhealth;VT:energy/vitality;BP:bodypain;
GH: general perception of health; aNo signiﬁcant diﬀerence between AG
and SG groups (P>. 05). bSigniﬁcant diﬀerence between baseline and 4W
(P ≤ .05). cNo signiﬁcant diﬀerence between baseline and 4W (P>. 05).
is the ﬁrst study showing that auricular pressure with low-
dose Alprazolam and Zolpidem improves anxiety symptoms,
menopausal symptoms, and quality of life in PPWA. The
results also show that the dosage of drugs can be gradually
reduced during the course of treatment to help avoid long-
term drug use that could induce dependence. The present
study was only one participant feeling dizziness in the AG,
but none in the SG; therefore, the treatment was safe and the
side eﬀect was minimal. However, participants in the AG and
theSGcouldnotpredictwhichgroupwouldshowsigniﬁcant
improvements. The results are consistent with those of
previous studies that found auricular pressure eﬀective for
treating anxiety [25]a n da n x i e t yb e f o r es u r g e r y[ 26]a n d
for improving quality of life [27]. Evidence-based studies
on the eﬃcacy of acupuncture have compared the eﬃcacy
of real and control acupuncture for clinical conditions such
as postmenopausal vasomotor symptoms in women [28],
including primary dysmenorrhea [29], insomnia [30], and
weight loss [31], ﬁnding improvement in real and control
acupuncture and showing no statistical diﬀerence between
the 2 groups. However, most of the studies did not design a
treatment group without intervention as a control, instead
using a noninvasive method as the control group; therefore,
theplaceboeﬀectmayhavecontributedtotheirresults.Some
scholarshaveindicatedthatshamacupuncturedoesnotexist
because true acupuncture and sham acupuncture could have
similar eﬀects on the central nervous or endocrine systems
[32, 33].
The choice of the ear shenmen and subcortex acupoints
was based on the meridian theory of traditional Chinese me-
dicine with a sedative mechanism to regulate cortical exci-
tation and inhibit brain function. Auricular acupressure on
these acupoints may alleviate the stimulating eﬀect of anxi-
ety, which promotes blood circulation through the nerve
channels. It may also stimulate the small myelinated nerve
in the spinal cord, midbrain, pituitary, and hypothalamus,
causing the release of endorphins into the bloodstream [34].6 Evidence-Based Complementary and Alternative Medicine
At the end of this study, the average Alprazolam dosage
in the AG was 0.3mg/day and in the SG was 0.5mg/day. No
statistically signiﬁcant diﬀerence between the groups was
reached; however, in the AG, the diﬀerence in drug use be-
tween the beginning and end of the study reached statistical
signiﬁcance. A previous study showed that 1.5 to 3mg of
Alprazolam per day can improve moderate to severe anxiety
and has antidepressant eﬀects [35]. Our participants entered
the study with mild to moderate anxiety. However, the av-
erage dosage remains lower than the general therapeutic
dose in clinical use. Further research is required to adjust the
experimental design using a ﬁxed dosage of combination
drugs to distinguish the diﬀerence between the 2 groups.
The present study has several limitations: (1) The sample
size was small. With the ﬁrst error set to 0.05 and the second
error set to 0.2, the power of this study was 0.9; for the study
to detect a signiﬁcant diﬀerence in therapeutic eﬀect, each
group requires at least 30 participants; (2) the participants
are all from a hospital in a rural area, and, therefore, the
resultsmaynotberepresentativeofotherareas;(3)ifthepar-
ticipants were interested in auricular acupressure or held a
positive viewofit beforethestudy,this waslikely toaﬀectthe
results of the study; (4) we had no untreated group as a con-
trol. As mentioned, sham acupuncture had a similar eﬀect,
butadesignconsideringthiscannotbeadouble-blindexper-
imental design. Previous studies did not directly compare
the eﬃcacy of auricular acupressure with diﬀerent methods
such as rapeseed, Vaccaria son, mustard seed, and magnetic
beads in reducing anxiety; therefore, future studies might
consider them; (5) the therapeutic relationship may provide
afeelingofrelaxation,causingparticipantstofeellessanxiety
or less distressed, consciously or unconsciously driven by the
hope of achieving clinical improvement; (6) the timeframe
for our study is only 4 weeks. We cannot predict whether the
therapeutic eﬀect would be maintained over a longer period;
(7) the magnet beads displaced from the acupoint may result
inthesimilareﬀectastheshamgroup.Inthefuture,wecould
design a study that, after using a combination of drugs and
auricular pressure for 4 weeks, uses auricular acupressure
alone as treatment for a set time. This could avoid drug
dependency and assess whether auricular acupressure alone
can maintain beneﬁcial eﬀects.
Inconclusion,nodirectsupportwasfoundforourhypo-
thesisthatauricularacupressureisbetterthanshamacupres-
sure for improving anxiety, menopausal symptoms, and
quality of life. Participants improved whether receiving real
or sham acupressure. The dosage of medication decreased
signiﬁcantly in the auricular acupressure group, but not
the sham acupressure group. This may be indirect evidence
ofthebeneﬁtofsuchalternativetherapy.Researchtodevelop
more safe and eﬀective interventions using integrated com-
plementary therapy and Western treatment should be en-
couraged.Furtherstudywithalargersamplesizeisnecessary.
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